Ledger.Open graph →
SEC Form D · filed May 6, 2014

AVAXIA BIOLOGICS, Inc

Offering
$8.0M
Sold
$3.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Christopher S. Kiritsy · Lexington, MADirectorHenry S. Kay · Lexington, MADirectorDavid S. Poorvin · Lexington, MADirectorNada S. Jain · Lexington, MADirectorDavid S. Donabedian · Lexington, MADirectorRobert S. Manning · Lexington, MADirectorBarbara S. Fox · Lexington, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗